Recently, Rack1 overexpression is associated with targeted resistance in hepatocellular carcinoma and gastrointestinal stromal tumor29,49,50, and chemoresistance in gastric cancer and leukemia51,52. The gene discussed is RACK1; the disease is hepatocellular carcinoma.